Xbrane Biopharma

Major Shareholding Notification • Aug 6, 2021

Issuer Xbrane Biopharma AB

Holder

Avanza Bank Holding AB för Försäkringsaktiebolaget Avanza Pension

Instrument
------------	--

Instrument	Aktier
Before the transaction
Shares	Data not given*
Voting rights	Data not given*
Transaction
Reason for major shareholding notification Sell
Date	05/08/2021
Limit for number of shares	5 %
Limit for number of votes	5 %
After the transaction
Quantity
Shares	1,235,501
Directly held voting rights	0
Indirectly held voting rights	1,235,501
Percentage
Directly held shares	4.93 %
Directly held voting rights	0 %
Indirectly held voting rights	4.93 %

Resulting distribution of total holdings

	Percentage of voting rights:	Number of underlying shares:
Shares	4.93 %	1,235,501
Instruments - FITA Ch. 4, section 2, first paragraph, line 2
Instruments - FITA Ch. 4, section 2, first paragraph, line 3
- Physically settled
- Cash settled	0.03 %	6,427
Total	4.96 %	1,241,928

Group total holdings

Voting rights 1,241,928 Percentage of voting rights 4.96

Notes (other relevant informations according to law)

Aktierna, samt övriga instrument enligt LHF 4 kap, 2§ första stycket 1 och finansiella instrument enligt LHF 4 kap. 2§ första stycket 3 innehas av Försäkringsaktiebolaget Avanza Pension som är ett helägt dotterbolag till Avanza Bank Holding AB (publ). Det är försäkringskunder som via depåfullmakt har avyttrat de aktuella aktierna.

Published

06/08/2021 15:31

Contact

Name Jonas Lexmark Phone 08-40942107 Email jonas.lexmark@avanza.se

*Source of information has chosen not to submit the data

rapportering@fi.se Tfn 08-408 980 37 Fax 08-24 39 25